PedAM
Pediatric Disease Annotations & Medicines
| Disease | rheumatoid arthritis |
| Phenotype | |cardiovascular disease |
| Sentences | 64 |
| PubMedID- 22284683 | We also suggest strategies for risk stratification and treatment of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23079082 | Introduction: recent studies revealed that co-morbidity and mortality due to cardiovascular disease are increased in patients with rheumatoid arthritis (ra) but little is known about factors involved in these manifestations. |
| PubMedID- 26082375 | [pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis]. |
| PubMedID- 22337612 | Apolipoprotein b-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 26362702 | Objective: to identify risk factors for cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 23848174 | cardiovascular diseases in patients with rheumatoid arthritis: comment on the article by koivuniemi et al. |
| PubMedID- 21385539 | Lack of association between lep rs2167270 (19 g>a) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 20383550 | Atherosclerosis plays a key role in cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 23204310 | Atherosclerosis and cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 25969671 | Several epidemiological studies reported increased morbidity and mortality from cardiovascular diseases in patients with rheumatoid arthritis [2], and strong evidences from basic research and epidemiological studies support that inflammation and venous thrombosis are associated processes [3]. |
| PubMedID- 21180241 | Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21269581 | Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22360682 | Lack of association between tlr4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24498997 | Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24511540 | Suggests that vegfa polymorphisms do not seem to exert a significant influence on the risk of cardiovascular disease in patients with rheumatoid arthritis [6]. |
| PubMedID- 21420089 | Tnfa -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 22521305 | Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24585741 | Objective: despite numerous studies reporting increased cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra), the impact of ra on managing modifiable cvd risk factors remains understudied. |
| PubMedID- 21411091 | Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises. |
| PubMedID- 23244227 | Objectives: to study cardiovascular autopsy findings and the lifetime prevalence of cardiovascular diseases (cvds) in patients with rheumatoid arthritis (ra). |
| PubMedID- 21520672 | [excess mortality from cardiovascular disease in patients with rheumatoid arthritis--nsaid a possible cause. |
| PubMedID- 24498229 | Conclusion: in observational studies the finding of incident cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids is strongly confounded by indication due to high disease activity. |
| PubMedID- 22935383 | Objectives: the impact of metabolic risk factors on atherosclerotic cardiovascular disease (acvd) in patients with rheumatoid arthritis (ra) from developing populations is currently unknown. |
| PubMedID- 25754335 | rheumatoid arthritis (ra) associates with increased cardiovascular disease (cvd) mortality thought to be due to accelerated arterial disease. |
| PubMedID- 21388351 | Vascular endothelial growth factor a and cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 22337246 | Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 25011482 | Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21846359 | Ccr5delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. |
| PubMedID- 20735865 | Palomino-morales and colleagues [1] report the novel observation that a common polymorphism in the gene for methylene tetrahydrofolate reductase (mthfr) that markedly reduces enzyme activity (by as much as 65% in homozygotes) may predispose to the development of atherosclerotic cardiovascular disease (ascvd) in patients with rheumatoid arthritis (ra). |
| PubMedID- 22249350 | Risk factors for cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 20952464 | Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. |
| PubMedID- 26117596 | Prevention of cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 20040642 | Risk factors for cardiovascular disease in rheumatoid arthritis: defining treatment thresholds. |
| PubMedID- 23666917 | Objective: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd), but little is known about its association with another form of vascular disorder, venous thromboembolism (vte). |
| PubMedID- 23983474 | The effects of the il-6r and il-6st/gp130 genes on the risk for cardiovascular disease in patients with rheumatoid arthritis were assessed in patients with rheumatoid arthritis who were genotyped for the functional gene polymorphisms. |
| PubMedID- 21071477 | Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. |
| PubMedID- 24795506 | Lack of association between abo, ppap2b, adamst7, pik3cg, and ednra and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 26023546 | Evaluation of serum magnesium, lipid profile and various biochemical parameters as risk factors of cardiovascular diseases in patients with rheumatoid arthritis. |
| PubMedID- 21109513 | cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. |
| PubMedID- 25026799 | [cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy]. |
| PubMedID- 24874661 | Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis. |
| PubMedID- 20164773 | cardiovascular disease in rheumatoid arthritis: a step forward. |
| PubMedID- 23300117 | Objectives: to assess the effect of golimumab, with or without methotrexate (mtx), on serum lipids and inflammatory markers of cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra) in two phase 3, randomised, placebo-controlled trials (go-before and go-forward). |
| PubMedID- 21073447 | To assess the potential association between adipoq rs266729 and rs1501299 gene polymorphisms, either isolated or in combination, and cardiovascular disease in patients with rheumatoid arthritis (ra), 674 patients seen at the rheumatology outpatient clinics of hospital xeral-calde, lugo, and hospital san carlos, madrid, spain, were analyzed. |
| PubMedID- 20827876 | cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. |
| PubMedID- 23584985 | Novel risk factors for cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 20842919 | [cardiovascular diseases in rheumatoid arthritis]. |
| PubMedID- 23256829 | The risk of cardiovascular disease associated with rheumatoid arthritis equals that of diabetes mellitus. |
| PubMedID- 22808986 | Different techniques have proven to be useful in determining the presence of subclinical cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 23818136 | Objective: to determine whether the impact of aging on cardiovascular disease (cvd) risk in patients with rheumatoid arthritis (ra) differs from that in the general population (as estimated by the framingham risk score [frs]). |
Page: 1 2